Document Detail

Safety of second-generation drug-eluting stents three years after randomised use in the TWENTE trial.
MedLine Citation:
PMID:  25136888     Owner:  NLM     Status:  Publisher    
Aims: To assess three-year clinical outcome following randomised use of the second-generation Resolute zotarolimus-eluting stent (ZES) and the XIENCE V everolimus-eluting stent (EES). For Resolute ZES and randomised use, outcome data ≥3 years are relatively scarce. Methods and results: The TWENTE trial examined 1,391 patients with stable angina or non-ST-elevation acute coronary syndromes, of whom 21.6% were diabetics, 70.1% had complex B2 or C lesions and 77.4% had "off-label" indications for DES use. Three-year follow-up data were obtained in 1,381 patients (99.3%; 10 withdrawals). Adverse clinical events were independently adjudicated. The primary endpoint target vessel failure (TVF), a composite of cardiac death, target vessel-related myocardial infarction and clinically indicated target vessel revascularisation, was 12.1% for Resolute ZES and 13.4% for XIENCE V EES (p=0.50). Cardiac death rates were 1.9% vs. 3.5% (p=0.06); the other individual components of TVF also showed no significant between-group differences. The rates of definite-or-probable stent thrombosis (1.4% vs. 1.6%, p=0.82) and very late stent thrombosis (0.6% vs. 0.4%, p=1.0) did not differ between the groups. Conclusions: Three-year follow-up data of patients included in the randomised TWENTE trial demonstrated similar and sustained safety and efficacy of Resolute ZES and XIENCE V EES.
Marije M Löwik; Ming Kai Lam; Hanim Sen; Kenneth Tandjung; K Gert van Houwelingen; Frits H A F de Man; Martin G Stoel; J Hans W Louwerenburg; Gerard C M Linssen; Carine J M Doggen; Clemens von Birgelen
Related Documents :
2772178 - Coronary artery calcifications: significance of incidental detection on ct scans.
16243738 - Ct angiography is here--are we expected to see a change of angiography referral pattern?
23936148 - Effect of folic acid supplementation on levels of circulating monocyte chemoattractant ...
16987628 - Accuracy of 16-detector multislice spiral computed tomography in the initial evaluation...
10652188 - Infarct size and nitric oxide synthase in murine myocardium.
18082488 - Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarct...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-8-20
Journal Detail:
Title:  EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology     Volume:  -     ISSN:  1969-6213     ISO Abbreviation:  EuroIntervention     Publication Date:  2014 Aug 
Date Detail:
Created Date:  2014-8-19     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101251040     Medline TA:  EuroIntervention     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Single bolus intravenous regadenoson injection versus central venous infusion of adenosine for maxim...
Next Document:  Investigation of manic and euthymic episodes identifies state- and trait-specific gene expression an...